SEC Form 4 · accession 0001415889-16-006147
ACADIA PHARMACEUTICALS INC · ACAD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mary Ann Gray
Director
Period of report
Jun 7, 2016
Accepted (ET)
Jun 9, 2016 · 5:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001070494
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 7, 2016 | M | 6,637 | $9.04 | A | 139,476 | D | |
| Common Stock | Jun 7, 2016 | M | 10,000 | $9.04 | A | 149,476 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F1 | $9.04 | Jun 7, 2016 | M | 6,637 | D | — | Jun 12, 2016 | Common Stock | 6,637 | 0 | D |
| Stock option (right to buy)F1 | $9.04 | Jun 7, 2016 | M | 10,000 | D | — | Jun 12, 2016 | Common Stock | 10,000 | 0 | D |
Explanation of responses
- F125% of the shares subject to the Stock Option vested and became exercisable at the end of each 3-month period following the date of grant of June 13, 2006.